| Features: Therapy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Regular physical activity has been shown to influence cancer risk, progression, and survivorship. While exercise is not a cure for cancer, extensive research indicates that it can help reduce the risk of developing certain types of cancer and improve outcomes and quality of life for those diagnosed. -Lowering the levels of hormones levels. -Preventing high blood levels of insulin. -Regular physical activity leads to decreased levels of inflammatory markers (such as C-reactive protein and interleukin-6). -Improving immune system function (enhancing the circulation of immune cells, including natural killer cells, T lymphocytes, and macrophages) -Reducing the time it takes for food to travel through the digestive system. -Helping to prevent obesity, which is a risk factor for many cancers. -Exercise promotes the upregulation of antioxidant defenses. Exercise simultaneously modulates multiple core cancer drivers: ↓ Insulin / IGF-1 signaling ↓ Chronic inflammation (IL-6, TNF-α baseline) ↑ Immune surveillance (NK cells, CD8⁺ T cells) ↑ Mitochondrial function and mitophagy ↓ Estrogen and androgen bioavailability ↑ Circadian stability ↓ Visceral adiposity (key endocrine organ) No supplement or single molecule does this breadth of work. Exercise, fasting, and diet work by changing the environment tumors depend on — not by poisoning the tumor. Age-stratified interpretation 1. Younger / metabolically healthy adults -Baseline IGF-1: normal–high -Exercise effect: -Systemic IGF-1 ↔ or slight ↓ -IGF-1 signaling efficiency ↑ (better receptor sensitivity) -Net effect: -Less chronic growth drive -Better metabolic control ➡ This is where IGF-1 ↓ papers usually come from. 2. Older adults (≈50–60+ years) -Baseline IGF-1: low -Exercise effect: -IGF-1 ↑ (restoration toward youthful range) -Improved GH → IGF-1 axis responsiveness -Net effect: -Muscle, bone, immune maintenance -Reduced frailty and inflammation ➡ This is where IGF-1 ↑ papers come from. 3. Cancer relevance (critical distinction) -Even when circulating IGF-1 increases in older exercisers: -Tumor IGF-1 signaling still goes DOWN, because: -Insulin sensitivity improves -IGFBP balance shifts -Inflammation drops -mTOR tone is suppressed -AMPK tone is elevated So: -Host IGF-1 ↑ ≠ tumor IGF-1 signaling ↑Exercise — Cancer vs Normal Cell Effects
Exercise — Alzheimer’s Disease & Cognitive Decline
|
| Source: |
| Type: |
| HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a surrogate index of: -Insulin resistance -Compensatory hyperinsulinemia Functionally, a high HOMA-IR indicates chronic activation of insulin–IGF signaling, which is directly oncogenic. HOMA-IR < 1.0: Low oncogenic insulin signaling HOMA-IR 1.5–2.5: Mild risk amplification HOMA-IR > 2.5–3.0: Sustained oncogenic signaling environment Reducing HOMA-IR downregulates oncogenic signaling: -Caloric restriction / fasting -Exercise (↑ insulin sensitivity, ↑ irisin) -AMPK activation (e.g., metformin) -Weight reduction (↓ leptin, ↓ resistin A high HOMA-IR reflects a pro-cancer signaling state, characterized by: -PI3K–AKT–mTOR hyperactivation -Loss of metabolic checkpoints -Inflammation–hormone synergy |
| 5061- | Ex, | Role of physical exercise in modulating the insulin-like growth factor system for improving breast cancer outcomes: A meta-analysis |
| - | Review, | BC, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:171 Target#:1425 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid